Susan Hasty, Publisher
Table of Contents . . . November 18th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Hemophilia - Combination therapy effective for hemophiliacs with chronic hepatitis C
Hepatitis C Virus Therapy - Higher doses of ribavirin increase risk for anemia in chronic hepatitis C
Blood Transfusion - Unsuspected and unreported infection may be cause of Japanese liver cancers
Hepatitis C Complications - Patients with myocarditis, hepatitis C virus, respond to immunosuppression
Hepatitis C Virus Detection - Assay for hepatitis C core antigen suggests storage degrades viral components
Appointments - Drug discovery company names new chief financial officer
Cancer Therapy - License option agreement signed for cancer epitopes for ex vivo applications
Cellular Therapy - CellExSys and Itochu partnership announced
Drug Delivery - System to administer medications has several applications
Finance - Company's third quarter revenue positively affected by HIV, HCV contracts
Legal Issues - Drug manufacturers settle royalty payment arbitration
Liver Cancer - Radiofrequency ablation benefits most with unresectable liver cancers
Liver Transplantation - Steroid tapering after liver transplant affects hepatitis C recurrence
Transplantation Risk Factors - Kidney dysfunction a late complication of liver transplantation
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.